Esophageal motor disorders

Current Opinion in Gastroenterology

Volumn 19, Issue 4, 2003, Pages 379-386

  Prakash, Chandra ^a   Clouse, Ray E ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Gastroenterology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CISAPRIDE; SILDENAFIL;

ANTIREFLUX OPERATION; CHAGAS DISEASE; CLINICAL FEATURE; CRICOPHARYNGEUS MUSCLE; DIAGNOSTIC PROCEDURE; DYSPHAGIA; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS MOTILITY; ESOPHAGUS SURGERY; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HUMAN; LOWER ESOPHAGUS SPHINCTER; LOWER ESOPHAGUS SPHINCTER PRESSURE; MANOMETRY; MOTOR DYSFUNCTION; MYOTOMY; PATHOPHYSIOLOGY; REFLUX ESOPHAGITIS; REVIEW; SIDE EFFECT; SPASTICITY; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME; UPPER ESOPHAGUS SPHINCTER; VOMITING; ZENKER DIVERTICULUM;

EID: 0037999865     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200307000-00010     Document Type: Review

References (69)

1. Esfandyari T, Potter JW, Vaezi MF: Dysphagia: a cost analysis of the diagnostic approach. Am J Gastroenterol 2002, 97:2733-2737. In the primary care setting, upper endoscopy is a better initial study for dysphagia than barium radiography, especially when endoscopic therapy is anticipated.
2. Walamies MA: Perception of esophageal manometry. Dis Esophagus 2002, 15:46-49. Esophageal manometry is a safe diagnostic technique with no serious complications.
3. Ragunath K, Williams JG: A review of oesophageal manometry testing in a district general hospital. Postgrad Med J 2002, 78:34-36. Esophageal manometry is increasingly used for investigation of unexplained dysphagia, but not for chest pain.
4. Arca MJ, Gagner M, Garcia-Ruiz A, et al.: The significance of pH and manometric testing after laparoscopic fundoplication. Surg Endosc 2002, 16:395-400.
5. Ertekin C, Aydogdu I: Electromyography of human cricopharyngeal muscle of the upper esophageal sphincter. Muscle Nerve 2002, 26:729-739.
6. Williams RB, Wallace KL, Ali GN, et al.: Biomechanics of failed deglutitive upper esophageal sphincter relaxation in neurogenic dysphagia. Am J Physiol Gastrointest Liver Physiol 2002, 283:G16-G26. An excellent study of the biomechanics involved in UES dysfunction resulting from different causes.
7. Schulze SL, Rhee JS, Kulpa JI, et al.: Morphology of the cricopharyngeal muscle in Zenker and control specimens. Ann Otol Rhinol Laryngol 2002, 111:573-578. Progressive denervation of the cricopharyngeal muscle leads to morphologic changes in the muscle fibers, impairing relaxation and contributing to muscle dysfunction in patients with Zenker diverticulum.
8. Leibovitz A, Sela BA, Habot B, et al.: Homocysteine blood level in long-term care residents with oropharyngeal dysphagia: comparison of hand-oral and tube-enteral-fed patients. JPEN J Parenter Enteral Nutr 2002, 26:94-97. A demonstration that oropharyngeal dysphagia managed with enteral tube feedings can lead to vitamin deficiencies that may be overlooked by routine laboratory tests.
9. Shaker R, Easterling C, Kern M, et al.: Rehabilitation of swallowing by exercise in tube-fed patients with pharyngeal dysphagia secondary to abnormal UES opening. Gastroenterology 2002, 122:1314-1321. Suprahyoid muscle strengthening exercises may improve deglutition and allow withdrawal of tube feedings in patients with UES dysfunction.
10. Wai CT, Yeoh KG, Ho KY: Esophageal intubation with duodenoscope in the presence of pharyngeal pouch by a guidewire and catheter-guided technique. Surg Laparosc Endosc Percutan Tech 2002, 12:362-363.
11. Balaji NS, Peters JH: Minimally invasive surgery for esophageal motility disorders. Surg Clin North Am 2002, 82:763-782. A comprehensive review of the minimally invasive surgical options for management of motility disorders.
12. Counter PR, Hilton ML, Baldwin DL: Long-term follow-up of endoscopic stapled diverticulotomy. Ann R Coll Surg Engl 2002, 84:89-92.
13. Stoeckli SJ, Schmid S: Endoscopic stapler-assisted diverticulo-esophagostomy for Zenker's diverticulum: patient satisfaction and subjective relief of symptoms. Surgery 2002, 131:158-162. Endoscopic stapled diverticulotomy affords excellent patient satisfaction with very good symptom relief in Zenker diverticulum.
14. 2 laser. Otolaryngol Head Neck Surg 2002, 127:309-314. Endoscopic laser-assisted diverticulotomy is feasible and effective in Zenker diverticulum.
15. Gutschow CA, Hamoir M, Rombaux P, et al.: Management of pharyngoesophageal (Zenker's) diverticulum: which technique? Ann Thorac Surg 2002, 74:1677-1682. A comparison of minimally invasive and open approaches for the management of Zenker diverticulum.
16. Raut VV, Primrose WJ: Long-term results of endoscopic stapling diverticulotomy for pharyngeal pouches. Otolaryngol Head Neck Surg 2002, 127:225-229. Endoscopic stapled diverticulotomy for Zenker diverticulum is associated with 80% long-term success over 2- to 5-year follow-up.
17. Shapiro J: Zenker's diverticulum. Curr Treat Options Gastroenterol 2002, 5:81-84. A good review of management options in Zenker diverticulum.
18. Smith SR, Genden EM, Urken ML: Endoscopic stapling technique for the treatment of Zenker diverticulum vs standard open-neck technique: a direct comparison and charge analysis. Arch Otolaryngol Head Neck Surg 2002, 128;141-144. Endoscopic stapled diverticulotomy is associated with significantly shorter operative time, time to oral feedings, and hospital stay compared with open surgery.
19. Mirza S, Dutt SN, Minhas SS, et al.: A retrospective review of pharyngeal pouch surgery in 56 patients. Ann R Coll Surg Engl 2002, 84:247-251.
20. Mattinger C, Hormann K: Endoscopic diverticulotomy of Zenker's diverticulum: management and complications. Dysphagia 2002, 17:34-39.
21. Ruiz-de-Leon A, Mendoza J, Sevilla-Mantilla C, et al.: Myenteric antiplexus antibodies and class II HLA in achalasia. Dig Dis Sci 2002, 47:15-19. Over half of achalasia patients demonstrate antibodies against myenteric plexus, as compared with only 8% of control subjects.
22. Dantas RO: Vigorous achalasia in Chagas' disease. Dis Esophagus 2002, 15:305-308.
23. Pajecki D, Zilberstein B, dos Santos MA, et al.: Megaesophagus microbiotica: a quaiitative and quantitative analysis. J Gastrointest Surg 2002, 6:723-729. Concentration of bacteria in esophageal contents increases with severity of megaesophagus.
24. Houlden H, Smith S, De Carvalho M, et al.: Clinical and genetic characterization of families with triple A (Allgrove) syndrome. Brain 2002, 125:2681-2690.
25. Goizet C, Catargi B, Tison F, et al.: Progressive bulbospinal amyotrophy in triple A syndrome with AAAS gene mutation. Neurology 2002, 26:962-965.
26. Hirota S, Nishida T, Isozaki K, et al.: Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene. Gastroenterology 2002, 122:1493-1499. First report of familial dysphagia due to mutation of KIT gene, with esophageal body aperistalsis and hyperpiasia of the myenteric plexus layer on esophageal testing.
27. Liu M, Gackler W, Rice TW, et al.: The pathogenesis of pseudoachalasia: a clinicopathologic study of 13 cases of a rare entity. Am J Surg Pathol 2002, 26;784-788. An elegant study demonstrating tumor invasion of esophageal myenteric plexus as the most common mechanism of malignancy-related pseudoachalasia.
28. Stylopoulos N, Bunker CJ, Rattner DW: Development of achalasia secondary to laparoscopic Nissen fundoplication. J Gastrointest Surg 2002,6:368-376.
29. Awad ZT, Selima MA, Filipi CJ: Pseudoachalasia as a late complication of gastric wrap performed for morbid obesity: report of a case. Surg Today 2002, 32:906-909.
30. Hussain SZ, Thomas R, Tolia V: A review of achalasia in 33 patients. Dig Dis Sci 2002, 47:2538-2543.
31. Blam ME, Delfyett W, Levine MS, et al.: Achalasia: a disease of varied and subtle symptoms that do not correlate with radiographic findings. Am J Gastroenterol 2002, 97:1916-1923. Subtle and atypical esophageal symptoms may delay achalasia diagnosis, but severity and number of symptoms do not correlate with magnitude of radiographic findings.
32. West RL, Hirsch DP, Bartelsman JF, et al.: Long term results of pneumatic dilation in achalasia followed for more than 5 years. Am J Gastroenterol 2002, 97:1346-1351. Pneumatic dilation results in lasting relief of achalasia symptoms in only 40% to 50% of patients over a mean 12-year follow-up.
33. Guo JP, Gilman PB, Thomas RM, et al.: Barrett's esophagus and achalasia. J Clin Gastroenterol 2002, 34:439-443.
34. Storr M, Born P, Frimberger E, et al.: Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment. BMC Gastroenterol 2002;13:19. A demonstration that botulinum toxin injection can be effective for short-term symptom management even for patients in whom prior achalasia treatments have failed.
35. D'Onofrio V, Miletto P, Leandro G, et al.: Long-term follow-up of achalasia patients treated with botulinum toxin. Dig Liver Dis 2002, 34:105-110. Symptom relief does not correlate with changes in objective measurements in patients with achalasia treated with botulinum toxin injection.
36. Neubrand M, Scheurlen C, Schepke M, et al.: Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy 2002, 34:519-523. Older patients with lower LES pressures demonstrate the most durable responses to botulinum toxin injection.
37. Penagini R, Cantu P, Mangano M, et al.: Long-term effects of pneumatic dilatation on symptoms and lower oesophageal sphincter pressure in achalasia. Scand J Gaetroenterol 2002, 37:380-384.
38. Sabharwal T, Cowling M, Dussek J, et al.: Balloon dilation for achalasia of the cardia: experience in 76 patients. Radiology 2002, 224:719-724.
39. Dolan K, Zafirellis K, Fountoulakis A, et al.: Does pneumatic dilatation affect the outcome of laparoscopic cardiomyotomy? Surg Endosc 2002, 16:84-87. This study confirms that laparoscopic myotomy is safe and feasibie after failed pneumatic dilation.
40. Vaezi MF, Baker ME, Achkar E, et al.: Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment. Gut 2002, 50:765-770. Further evidence of the utility of the timed barium swallow: improvement in upright barium column height (measured 5 minutes after administration of a fixed barium volume) correlates directly with long-term response to pneumatic dilation, especially when symptoms improve as well.
41. Khan AA, Shah SW, Alam A, et al.: Efficacy of Rigiflex balloon dilation in 12 children with achalasia: a 6-month prospective study showing weight gain and symptomatic improvement. Dis Esophagus 2002, 15:167-170. Pneumatic dilation with a 30-mm balloon is safe and effective in children with achalasia.
42. Chen LQ, Chughtai T, Sideris L, et al.: Long-term effects of myotomy and partial fundoplication for esophageal achalasia. Dis Esophagus 2002,15:171-179.
43. Sharp KW, Khaitan L, Scholz S, et al.: 100 consecutive minimally invasive Heller myotomies: lessons learnt. Ann Surg 2002, 235:631-638.
44. Fernandez AF, Martinez MA, Ruiz J, et al.: Six years of experience in laparoscopic surgery of esophageal achalasia. Surg Endosc 2003, 17:153-156.
45. Donahue PE, Horgan S, Liu KJ, et al.: Floppy Dor fundoplication after esophagocardiomyotomy for achalasia. Surgery 2002, 132:716-722.
46. Grigelat C, Schob O: Laparoscopic reoperation as management of severe gastroesophageal reflux following laparoscopic Heller myotomy for achalasia: a case report. Surg Laparosc Endosc Percutan Tech 2002, 12:208-211.
47. Gorecki PJ, Hinder RA, Libbey JS, et al.: Redo laparoscopic surgery for achalasia. Surg Endosc 2002, 16:772-776. Laparoscopic reoperation for failed myotomy is feasible, with overall good results.
48. Bloomston M, Brady P, Rosemurgy AS: Videoscopic Heller myotomy with intraoperative endoscopy promotes optimal outcomes. JSLS 2002, 6:133-138. Intraoperative endoscopy may direct length and adequacy of laparoscopic myotomy and help preserve natural antireflux mechanisms.
49. Zaninotto G, Costantini M, Portale G, et al.: Etiology, diagnosis, and treatment of failures after laparoscopic Heiier myotomy for achalasia. Ann Surg 2002, 235:186-192. Incomplete myotomy and sclerosis at the myotomy site are the commonest causes of surgical failures; both can be effectively treated with pneumatic dilation.
50. Miller KA, Holcomb GW III: Laparoscopic adrenalectomy and esophagomyotomy. Semin Pediatr Surg 2002, 11:237-244.
51. Bloomston M, Serafini F, Boyce HW, et al.: The "learning curve" in videoscopic Heller myotomy. JSLS 2002, 6:41-47. Clinical outcomes after videoscopic Heller myotomy improve after the surgeon has successfully completed 20 procedures.
52. Esposito C, Mattioli G, Monguzzi GL, et al.: Complications and conversions of pediatric videosurgery: the Italian multicentric experience on 1689 procedures. Surg Endosc 2002, 16:795-798.
53. O'Connor JB, Singer ME, Imperiale TF, et al.: The cost-effectiveness of treatment strategies for achalasia. Dig Dis Sci 2002, 47:1516-1525. The high initial cost of surgery makes pneumatic dilation the most cost-effective management option for achalasia over medium-term follow-up.
54. Zarate N, Mearin G, Baldovino F, et al.: Achalasia treatment in the elderly: is botulinum toxin injection the best option? Eur J Gastroenterol Hepatol 2002, 14:285-290.
55. Decker G, Borie F, Bouamrirene D, et al.: Gastrointestinal quality of life before and after laparoscopic Heller myotomy with partial posterior fundoplication. Ann Surg 2002, 236:750-758. GQLI improves significantly after laparoscopic myotomy and may be useful in comparing outcomes between management approaches in achalasia.
56. Faure C, Viarme F, Cargill G, et al.: Abnormal esophageal motility in children with congenital central hypoventilation syndrome. Gastroenterology 2002,122:1258-1263.
57. Pehlivanov N, Liu J, Kassab GS, et al.: Relationship between esophageal muscle thickness and intraluminal pressure in patients with esophageal spasm. Am J Physiol Gastrointest Liver Physiol 2002, 282:G1016-G1023. A study employing high-resolution intraluminal ultrasound for examining relationships of muscle layer thickness to intraluminal manometric findings.
58. Barreca M, Oelschlager BK, Pellegrini CA: Outcomes of laparoscopic Nissen fundoplication in patients with the "hypercontractile" esophagus. Arch Surg 2002, 137:724-728. Antireflux surgery is not contraindicated in the presence of spastic disorders, but nonreflux symptoms including chest pain may develop or persist after surgery.
59. Kamolz T, Granderath FA, Bammer T, et al.: "Floppy" Nissen vs. Toupet laparoscopic fundoplication: quality of life assessment in a 5-year follow-up. Endoscopy 2002, 34:917-922.
60. Clouse RE, Lustman PJ: Psychiatric illness and contraction abnormalities of the esophagus. N Engl J Med 1983,309:1337-1342.
61. Miller LS, Pulleta SV, Parkman HP, et al.: Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol 2002, 97:1640-1646. An uncontrolled study suggesting a benefit of botulinum toxin when injected at the gastroesophageal junction for chest pain associated with spastic disorders.
62. Eherer AJ, Schwetz I, Hammer HF, et al.: Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002, 50:758-764. Sildenafil decreases LES pressure and distal esophageal contraction amplitudes in spastic disorders, but side effects are limiting.
63. Nehra D, Lord RV, DeMeester TR, et al.: Physiologic basis for the treatment of epiphrenic diverticulum. Ann Surg 2002, 235:346-354. Epiphrenic diverticula occur as sequelae of spastic esophageal disorders.
64. Neoral C, Aujesky R, Bohanes T, et al.: Laparoscopic transhiatal resection of epiphrenic diverticulum. Dis Esophagus 2002, 15:323-325.
65. Nastos D, Chen LQ, Ferraro P, et al.: Long myotomy with antireflux repair for esophageal spastic disorders. J Gastrointest Surg 2002, 6:713-722.
66. Dantas RO, Aprile LR: Esophageal striated muscle contractions in patients with gastroesophageal reflux symptoms. Dig Dis Sci 2002, 47:2586-2590.
67. Wang SJ, La JL, Chen DY, et al.: Effects of cisapride on oesophageal transit of solids in patients with progressive systemic sclerosis. Clin Rheumatol 2002, 21:43-45.
68. Alrakawi A, Haroian L, Staiano A, et al.: Cisapride restores peristalsis in GERD patients with feeble esophageal peristalsis [abstract]. Gastroenterology 1997, 112:A57.
69. Hui JM, Hunt DR, de Carle D J, et al.: Esophageal pneumatic dilation for post-fundoplication dysphagia: safety, efficacy, and predictors of outcome. Am J Gastroenterol 2002, 97:2986-2991. Pneumatic dilation is safe and effective in postfundoplication dysphagia.